These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18838214)

  • 1. Prostate stem cell antigen: a prospective therapeutic and diagnostic target.
    Raff AB; Gray A; Kast WM
    Cancer Lett; 2009 May; 277(2):126-32. PubMed ID: 18838214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
    Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prostate stem cell antigen in prostate cancer research.
    Jalkut MW; Reiter RE
    Curr Opin Urol; 2002 Sep; 12(5):401-6. PubMed ID: 12172427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
    Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
    Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
    Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
    Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate stem cell antigen: a Jekyll and Hyde molecule?
    Saeki N; Gu J; Yoshida T; Wu X
    Clin Cancer Res; 2010 Jul; 16(14):3533-8. PubMed ID: 20501618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z; Wenlv S
    Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.
    Yang X; Guo Z; Liu Y; Si T; Yu H; Li B; Tian W
    Expert Rev Anticancer Ther; 2014 Jan; 14(1):31-7. PubMed ID: 24308679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
    Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
    PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
    Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
    Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma.
    Zhigang Z; Wenlu S
    Prostate; 2005 Dec; 65(4):299-305. PubMed ID: 16015594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
    Dubey P; Wu H; Reiter RE; Witte ON
    Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
    Saffran DC; Raitano AB; Hubert RS; Witte ON; Reiter RE; Jakobovits A
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2658-63. PubMed ID: 11226295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
    Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
    Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells.
    Morgenroth A; Cartellieri M; Schmitz M; Günes S; Weigle B; Bachmann M; Abken H; Rieber EP; Temme A
    Prostate; 2007 Jul; 67(10):1121-31. PubMed ID: 17492652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.
    Arndt C; Feldmann A; Töpfer K; Koristka S; Cartellieri M; Temme A; Ehninger A; Ehninger G; Bachmann M
    Prostate; 2014 Sep; 74(13):1347-58. PubMed ID: 25053504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
    Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
    Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.
    Xiang Q; Zhu Z; Luo L; Wang J; Liu Y; Deng Y; Zhou M; Zhao Z
    Biomed Res Int; 2020; 2020():5395312. PubMed ID: 33029516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.